Pharmala Biotech Holdings Statistics

Total Valuation

CSE:MDMA has a market cap or net worth of CAD 10.57 million.

Market Cap	10.57M
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:MDMA has 105.68 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	105.68M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.57
PB Ratio	3.42
P/TBV Ratio	8.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.57

Current Ratio	2.57
Quick Ratio	2.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.89% and return on invested capital (ROIC) is -50.66%.

Return on Equity (ROE)	-86.89%
Return on Assets (ROA)	-35.19%
Return on Invested Capital (ROIC)	-50.66%
Return on Capital Employed (ROCE)	-58.12%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.00% in the last 52 weeks. The beta is 0.96, so CSE:MDMA's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-12.00%
50-Day Moving Average	0.12
200-Day Moving Average	0.19
Relative Strength Index (RSI)	51.35
Average Volume (20 Days)	245,223

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:MDMA had revenue of CAD 430,181 and -1.93 million in losses. Loss per share was -0.02.

Revenue	430,181
Gross Profit	565,779
Operating Income	-1.80M
Pretax Income	-1.93M
Net Income	-1.93M
EBITDA	-1.80M
EBIT	-1.80M
Loss Per Share	-0.02

Balance Sheet

The company has 1.51 million in cash and n/a in debt, giving a net cash position of 1.51 million or 0.01 per share.

Cash & Cash Equivalents	1.51M
Total Debt	n/a
Net Cash	1.51M
Net Cash Per Share	0.01
Equity (Book Value)	3.09M
Book Value Per Share	0.03
Working Capital	1.28M

Cash Flow

Operating Cash Flow	-720,796
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	131.52%
Operating Margin	-417.99%
Pretax Margin	-448.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:MDMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-18.24%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:MDMA has an Altman Z-Score of 9 and a Piotroski F-Score of 1.

Altman Z-Score	9
Piotroski F-Score	1